✦ LIBER ✦

Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (EFficacy of FOSAMAX® versus EVISTA®Comparison Trial) International

✍ Scribed by P. N. Sambrook; P. Geusens; C. Ribot; J. A. Solimano; J. Ferrer-Barriendos; K. Gaines; N. Verbruggen; M. E. Melton

Book ID: 108861878
Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 98 KB
Volume: 255
Category: Article
ISSN: 0954-6820
DOI: 10.1111/j.1365-2796.2004.01317.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Alendronic Acid Produces Greater Effects

Alendronic Acid Produces Greater Effects than Risedronic Acid on Bone Density and Turnover in Postmenopausal Women with Osteoporosis

✍ Dr David M. Reid, David Hosking, David Kendler, Maria L. Brandi, John D. Wark, G 📂 Article 📅 2006 🏛 Springer International Publishing AG 🌐 English ⚖ 153 KB

Comparison of the effect of alendronate

Comparison of the effect of alendronate on lumbar bone mineral density and bone turnover in men and postmenopausal women with osteoporosis

✍ Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato; Mitsuyoshi Uzawa 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 121 KB

Effect of raloxifene on bone mineral den

Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial

✍ H. Morii; Y. Ohashi; Y. Taketani; M. Fukunaga; T. Nakamura; A. Itabashi; S. Sark 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 268 KB

Multinational, Placebo-Controlled, Rando

Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study

✍ H. A. P. Pols; D. Felsenberg; D. A. Hanley; J. Štepán; M. Muñoz-Torres; T. J. Wi 📂 Article 📅 1999 🏛 Springer-Verlag 🌐 English ⚖ 86 KB

Four-year results of a phase 2 study of

Four-year results of a phase 2 study of the cathepsin K inhibitor odanacatib in postmenopausal women with low bone mineral density: Effects on bone mineral density and bone turnover markers

✍ H. Resch; N. Binkley; H. Bone; J. Eisman; D. Hosking; B. Langdahl; M. McClung; I 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB

Four-year Results of a Phase 2 Study of

Four-year Results of a Phase 2 Study of the Cathepsin K Inhibitor Odanacatib in Postmenopausal Women with Low Bone Mineral Density: Effects on Bone Mineral Density and Bone Turnover Markers

✍ Miller, Paul; Binkley, Neil; Eisman, John; Reid, Ian; Lombardi, Antonio 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB